Helen Figge kicked off this panel analyzing digital health’s biggest hurdles when addressing and engaging women’s health. Leveraging both her decades of experience within the space and her own research of female health and mortality, Helen dived into the future of a more digitally connected woman. Following her introduction, these leaders broke down the barrier between medicine and gender, by examining the solutions that span a woman’s life and how the future of medicine can become more aware of gender.
MedClinik is a technoogy company dedicated to develop and market patient-centric solutions to improve screening, diagnosis and treatment self-management. Claire presented their product, TAVIE, which is the world’s first clinically validated VirtualNurse platform, with personalized and interactive patient support to optimize treatment adherence
At TrialReach, we make patients getting in touch with researchers (and vice versa) simple, clear and quick — so that new drugs and life changing treatments can reach the people who need them faster.
Paul Bonnet is managing Vidal Group operations for Latin America and Spain. After 10 years of distribution developement for telecommunications carriers in France, he led over the last seven years the digital transition and internationalization of Vidal Group in Spain, Mexico, Ecuador and Chile consolidating strategic relations with both private and public stakeholders. Vidal Vademecum is part of Vidal Group, a leading European healthcare informatics and information systems company.
Vital Connect is a global provider of medical-grade bio sensors that monitor your vital signs. As President of Vital Connect, Michael demonstrated and discussed how their wearable device will change health care.